Skip NavigationSkip to Content
Return Return to Search Results

Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma

  1. Author:
    Liu, Qiang
    Cui, Xiang
    Yu, Xi
    Bian, Bai-Shi-Jiao
    Qian, Feng
    Hu, Xu-Gang
    Ji, Cheng-Dong
    Yang, Lang
    Ren, Yong
    Cui, Wei
    Zhang, Xia
    Zhang, Peng
    Wang, Jiming
    Cui, You-Hong
    Bian, Xiu-Wu

  2. Author Address

    Institute of Pathology and Southwest Cancer Center, and Key Laboratory of Tumor Immunopathology of Ministry of Education of China, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China., Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, China., Department of General Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China., Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA., Institute of Pathology and Southwest Cancer Center, and Key Laboratory of Tumor Immunopathology of Ministry of Education of China, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China. cuiyouhongx@yahoo.com., Institute of Pathology and Southwest Cancer Center, and Key Laboratory of Tumor Immunopathology of Ministry of Education of China, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China. bianxiuwu@263.net.,
    1. Year: 2017
    2. Date: Apr 21
    3. Epub Date: 2017 Apr 21
  2. Journal: MOLECULAR CANCER
    1. 16
    2. 1
    3. Pages: 81
  4. Type of Article: Article
  5. Article Number: 81
  1. Abstract:

    Esophageal squamous cell carcinoma (ESCC) is highly malignant with highly invasive and metastatic capabilities and poor prognosis. It is believed that the ESCC cancer stem-like cells (ECSLCs) are critical for tumorigenicity, invasion and metastasis of ESCC. However, the properties of ECSLCs vary with different markers used in isolation, so that new and more effective markers of ECSLCs need to be identified. This study aimed to estimate the potentiality of Cripto-1 (CR-1) as an ECSLC surface marker and investigate the clinical significance of CR-1 expression in ESCC. ESCC cells with CR-1 (high) or CR-1(low) were obtained by flow cytometry then their self-renewal capability and tumorigenicity were compared by colony and limiting dilution sphere formation analysis in vitro and xenograft in nude mice in vivo, respectively. Knockdown of CR-1 expression in ESCC cells was conducted with short hairpin RNA. Cell migration and invasion were examined by scratch test and matrigel transwell assay, respectively. Metastatic capability of ESCC cells was assayed by a mouse tail vein metastasis model. The levels of CR-1 expression in cancerous and paired adjacent normal tissues were assessed by IHC and qRT-RCR. CR-1(high) subpopulation of ESCC cells isolated by FACS expressed high level of genes related to stemness and epithelial-mesenchymal transition (EMT), and possessed high capacities of self-renewal, tumorigenesis, invasion and metastasis. Suppression of CR-1 expression significantly reduced the expression of stemness- and EMT-related genes and the capabilities of self-renewal in vitro, tumorigenicity and metastasis in vivo in ESCC cells. In the clinical ESCC specimens, the expression levels of CR-1 in cancerous tissues were positively correlated to TNM stage, invasive depth, and lymph node metastasis. Cox regression analysis indicated that CR-1 was an independent indicator of prognosis. The expression of CR-1 was found overlapping with aldehyde dehydrogenase 1A1 (ALDH1A1), an intracellular marker for ESCLCs, in ESCC cell lines and specimens. CR-1 is a functional and cell surface ECSLC marker, and an independent prognostic indicator as well as a potential therapeutic target for ESCC.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1186/s12943-017-0650-7
  3. PMID: 28431580
  4. View record in Web of Science®
  5. WOS: 000399771800001

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel